Cargando…
ASXL1 c.1934dup;p.Gly646Trpfs*12—a true somatic alteration requiring a new approach
Autores principales: | Yannakou, Costas K., Jones, Kate, McBean, Michelle, Thompson, Ella R., Ryland, Georgina L., Doig, Ken, Markham, John, Westerman, David, Blombery, Piers |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802455/ https://www.ncbi.nlm.nih.gov/pubmed/29242575 http://dx.doi.org/10.1038/s41408-017-0025-8 |
Ejemplares similares
-
The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring‐Opitz Syndrome
por: Urreizti, Roser, et al.
Publicado: (2018) -
Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era
por: Montes-Moreno, Santiago, et al.
Publicado: (2018) -
Comparative functional characterization of novel non-syndromic GJB2 gene variant p.Gly45Arg and lethal syndromic variant p.Gly45Glu
por: Rodriguez-Paris, Juan, et al.
Publicado: (2016) -
Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism
por: Sadhukhan, Dipanwita, et al.
Publicado: (2020) -
Atypical Hemolytic Uremic Syndrome (p.Gly1110Ala) with Autoimmune Disease
por: Park, Sihyung, et al.
Publicado: (2020)